Fed. Circ. Upholds Opana Patent Amid Generic Challenge
The Federal Circuit on Friday upheld the validity of a patent related to Endo Pharmaceuticals' opioid painkiller Opana ER, finding generic-drug maker Teva Pharmaceuticals had not shown the invention was obvious....To view the full article, register now.
Already a subscriber? Click here to view full article